Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
BridgeBio Pharma, Inc. (BBIO)
Sector: Healthcare; Industry: Biotechnology

BridgeBio Pharma, Inc. discovers and develops various medicines for genetic diseases. In addition, it is involved in the development of; BBP-551 to treat inherited retinal disease; BBP-472 to treat autism-spectrum disorder; BBP-009/Patidegib to treat gorlin syndrome and high-frequency basal cell carcinoma; BBP-589/PTR-01 to treat recessive dystrophic epidermolysis bullosa; BBP-681 to treat venous and lymphatic malformations; BBP-561 to treat netherton syndrome; BBP-398 to treat cancer; BBP-954 to treat solid and hematological cancers; BBP-812 for canavan disease; and BBP-815 to treat nonsyndromic hearing loss.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 STEPHENSON BRIAN C nan Buy 8,000 $62.50 $500,000 Yes
2021-02-17 Scott Randal W. Director Buy 16,000 $62.50 $1,000,000 No
2021-02-17 KKR Genetic Disorder L.P. 10%-Owner Sell 3,450,000 $60.47 $208,617,360 No
2020-12-28 Turtle Cameron nan Sell 19,500 $69.60 $1,357,184 Yes
2020-12-21 SCHELLER RICHARD H Director Sell 60,401 $65.32 $3,945,137 No
2020-12-18 SCHELLER RICHARD H Director Sell 30,000 $65.07 $1,952,021 No
2020-12-15 SCHELLER RICHARD H Director Sell 31,443 $60.38 $1,898,417 Yes
2020-12-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $51.52 $515,204 Yes
2020-06-03 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 784 $30.04 $23,549 No
2020-11-25 Turtle Cameron nan Sell 5,000 $47.04 $235,181 Yes
2020-11-16 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $45.00 $450,000 Yes
2020-11-13 MCCORMICK FRANK Chairman of Oncology Sell 100,000 $42.76 $4,275,769 No
2020-11-05 Turtle Cameron nan Sell 2,500 $42.05 $105,125 Yes
2020-11-02 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $38.36 $383,558 Yes
2020-10-16 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 10,256 $41.00 $420,496 Yes
2020-10-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $38.83 $388,342 Yes
2020-09-30 Turtle Cameron nan Sell 14,500 $37.69 $546,458 Yes
2020-09-30 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 10,000 $38.00 $380,000 Yes
2020-09-29 HOMCY CHARLES J Chairman of Pharmaceuticals Sell 99,257 $36.95 $3,667,955 No
2020-09-18 Turtle Cameron nan Sell 2,500 $42.01 $105,024 Yes
2020-09-18 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $40.00 $400,000 Yes
2020-09-16 SCHELLER RICHARD H Director Sell 25,000 $37.50 $937,500 No
2020-09-15 Turtle Cameron nan Sell 2,500 $37.06 $92,652 Yes
2020-09-11 Turtle Cameron nan Sell 2,000 $35.02 $70,047 Yes
2020-09-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $28.73 $287,334 Yes
2020-08-04 STEPHENSON BRIAN C nan Sell 7,200 $27.26 $196,289 No
2020-08-04 Kumar Neil CEO and President Sell 80,000 $27.23 $2,178,066 No
2020-08-03 HENDERSON MICHAEL THOMAS Chief Business Officer Sell 10,000 $27.37 $273,741 Yes
2020-07-02 Kumar Neil CEO and President Sell 143,470 $30.75 $4,411,357 No
2020-07-01 STEPHENSON BRIAN C nan Sell 10,800 $30.93 $334,053 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.